Equities

UDG Healthcare PLC

UDG Healthcare PLC

Actions
Health CareHealth Care Equipment & Services
  • Price (GBX)650.00
  • Today's Change-7.00 / -1.07%
  • Shares traded687.71k
  • 1 Year change18.83%
  • Beta0.7826
Data delayed at least 20 minutes, as of Jan 19 2017 16:59 GMT.
More ▼

Key statistics

On Thursday, UDG Healthcare PLC (UDG:LSE) closed at 650.00, -6.54% below its 52-week high of 695.50, set on Dec 09, 2016.
52-week range
Today
491.30Feb 09 2016695.50Dec 09 2016
Markit short selling activity
Low
Med
High
Open663.50
High663.50
Low643.00
Bid600.00
Offer--
Previous close657.00
Average volume1.24m
Shares outstanding247.65m
Free float209.99m
P/E (TTM)30.72
Market cap1.64bn GBP
EPS (TTM)0.2149 GBP
Annual div (ADY)10.02 GBX
Annual div yield (ADY)1.54%
Div ex-dateJan 19 2017
Div pay-dateFeb 13 2017
Data delayed at least 20 minutes, as of Jan 19 2017 16:59 GMT.
More ▼

Investors Chronicle View

The last IC recommendation on UDG Healthcare PLC shares was Buy at 625.00 on 25 Nov 2016Read the full article

Board of Directors

1/10

Peter Gray, Chairman

2/10

Brendan McAtamney, Chief Operating Officer

3/10

Alan Ralph, Chief Financial Officer

4/10

Chris Corbin, Managing Director of Ashfield Commercial and Medical Services

5/10

Liam FitzGerald, Non-Executive Director

6/10

Chris Brinsmead, Non-Executive Director

7/10

Gerard van Odijk, Non-Executive Director

8/10

Lisa Ricciardi, Non-Executive Director

9/10

Philip Toomey, Non-Executive Director

10/10

Linda Wilding, Non-Executive Director

Introduction to UDG Healthcare plc

Investor Relations Contact

Alan Ralph
CFO
UDG Healthcare House
Magna Drive
Magna Business Park
Citywest Road
Dublin 24
Ireland
 
David Marshall
Head of Investor Relations
UDG Healthcare House
Magna Drive
Magna Business Park
Citywest Road
Dublin 24
Ireland
 
Tel: +353 1 463 2300
Fax: +353 1 459 6893
© Thomson Reuters Click for restrictions
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.